Center fro Disabilities and Development
Iowa City, Iowa, 52246, United States
Location status: Recruiting
Location contact
John Pienta, MD
CONTACT
Lane Strathearn, MBBS FRACP PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07738003
The University of Iowa's Center for Disabilities and Development is researching how pregnancy, early childhood experiences, and genetic factors influence child development, with a focus on autism spectrum disorder (ASD). Pregnant women are invited to participate in a study that tracks their pregnancy and child's early development, through simple, at-home activities using a cell phone. Participants complete short questionnaires, join an online interview, and videotape their baby's play after birth. They are also sent a kit to swab their baby's mouth to collect cheek cells for genetic testing. The study will explore whether stress and early social experience lead to genetic changes associated with autism or other developmental conditions.
Interested in participating?
Request Info0 year–50 year
All sexes
Observational
Iowa City, Iowa, 52246, United States
Location status: Recruiting
John Pienta, MD
CONTACT
Lane Strathearn, MBBS FRACP PhD
PRINCIPAL_INVESTIGATOR
Autism spectrum disorder (ASD) is one of the most common neurodevelopmental disabilities, adversely affecting an increasing number of families worldwide. Although its etiology is strongly linked to genetic factors, perinatal experience, including prenatal stress and post-natal social experience, may also contribute to deficits in social communication in ASD, potentially via epigenetic mechanisms. For example, the oxytocin receptor gene (OXTR) is epigenetically altered by early social experience, plays a crucial role in mammalian social and cognitive development, and is associated with both genetic and epigenetic risk for ASD. However, the relationship between perinatal experience and epigenetic change in ASD is unclear. Our central hypothesis is that prenatal stress and early social experience predicts epigenetic changes in specific genes, which are associated with social communication deficits in ASD. To achieve our overall goal of discovering modifiable pathways for intervention in children at risk for ASD, we will recruit over 7,200 pregnant women to use a smartphone tool called BabySteps, to collect prospective data from the 3rd trimester of pregnancy until 30 months post-delivery. Between ages 18 to 27 months, BabySteps will be used to screen for symptoms of ASD or developmental delay (DD) in the offspring, which will trigger a full diagnostic assessment online or in person at the Center for Disabilities and Development. Children with a range of social communication deficits (including those diagnosed with ASD or non-ASD DD [n=200]) will be compared with typically developing children (TD; n=200) who are matched on race, sex, and socioeconomic status. We will examine 1) differences in DNA methylation (DNAm), and change over time, in specific ASD-associated loci and OXTR loci, and 2) differences in biologic age acceleration using epigenetic clock algorithms, as a function of age, perinatal experience, and social communication outcomes. We will compare DNAm from buccal swabs to samples collected around the time of diagnosis. We will calculate polygenic risk scores for social communication, repetitive behavior, and ASD, and assess the relative polygenic and epigenetic risk. The relationship between perinatal experience, DNAm, and social communication outcomes will be evaluated using 4 complementary measures: 1) ecological momentary assessments (EMAs) of prenatal stress and parental anxiety and depression, collected using BabySteps; 2) app-recorded free play between parent and child analyzed for dyadic synchrony and interactive behavior; 3) standardized assessments of child social communication skills; and 4) a Language ENvironment Analysis (LENA), using a LENA audio-recording device worn by the child at home and in daycare. We expect to identify epigenetic biomarkers that link prenatal stress and early social experience with social communication outcomes in ASD. A better understanding of how polygenic risk and perinatal experience-via epigenetic mechanisms-contribute to the ASD phenotype will help overcome a critical barrier to progress in the field, by identifying modifiable pathways for intervention.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
A. Criteria for Pregnant Women:
B. ASD Group at age 18 to 27 months
C. Developmental Delay (DD) Group at age 18 to 27-months
D. Typically Developing (TD) Group at age 18 to 27 months - None
Exclusion criteria
A. Criteria for Pregnant Women:
B. All children
C. ASD Group at age 18 to 27 months
D. Developmental Delay (DD) Group at age 18 to 27 months
E. Typically Developing (TD) Group at age 18 to 27 months
Time frame: 18-36 months
A continuous measure of child's social communication capacity
Time frame: 18-36 months
ASD, DD or TD
Contact information is provided by the study sponsor or research team.
John Pienta, MD
CONTACT
Lane Strathearn, MBBS FRACP PhD
CONTACT
University of Iowa
Other
Perinatal Experience and Epigenetic Change in Autism: Discovering Modifiable Pathways for Intervention
Acronym: PAGES
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07498049
Autism, Autism Disorder
Nottingham, United Kingdom
View Trial DetailsNCT05568303
Autism Disorders and Maternal Stress, Cognitive Behavioral Therapy and Problem Solving
Behera Governate, Beera, Egypt
View Trial DetailsNCT06399952
Autism Spectrum Disorder, Autism or Autistic Traits
Columbia, Missouri, United States
View Trial DetailsNCT06314438
Autism, Autism Spectrum Disorder
Kent, Washington, United States
View Trial Details